The most statistically significant gender differences in patients with GN concerned the percentage of CD19+CD200R+ B lymphocytes (MCD men vs. MN women; MCD women vs. MN women; MCD men vs. MN men; MCD women vs. MN men) (Figure 5E) and CD8+CD200+ lymphocytes (MCD women vs. MN men) (Figure 5D). This evidence concerns the gene CD19 and ganglioneuroma.